The University of Southampton
University of Southampton Institutional Repository

Health related quality of life, functional impairment and comorbidity in people with mild to moderate chronic kidney disease: a cross sectional study

Health related quality of life, functional impairment and comorbidity in people with mild to moderate chronic kidney disease: a cross sectional study
Health related quality of life, functional impairment and comorbidity in people with mild to moderate chronic kidney disease: a cross sectional study

OBJECTIVES: To determine the associations between comorbidities, health-related quality of life (HRQoL) and functional impairment in people with mild-to-moderate chronic kidney disease (CKD) in primary care.

DESIGN: Cross-sectional analysis at 5-year follow-up in a prospective cohort study.

SETTING: Thirty-two general practitioner surgeries in England.

PARTICIPANTS: 1008 participants with CKD stage 3 (of 1741 people recruited at baseline in the Renal Risk in Derby study) who survived to 5 years and had complete follow-up data for HRQoL and functional status (FS).

PRIMARY AND SECONDARY OUTCOME MEASURES: HRQoL assessed using the 5-level EQ-5D version (EQ-5D-5L, with domains of mobility, self-care, usual activities, pain/discomfort and anxiety/depression and index value using utility scores calculated from the English general population), and FS using the Karnofsky Performance Status scale (functional impairment defined as Karnofksy score ≤70). Comorbidity was defined by self-reported or doctor-diagnosed condition, disease-specific medication or blood result.

RESULTS: Mean age was 75.8 years. The numbers reporting some problems in EQ-5D-5L domains were: 582 (57.7%) for mobility, 166 (16.5%) for self-care, 466 (46.2%) for usual activities, 712 (70.6%) for pain/discomfort and 319 (31.6%) for anxiety/depression. Only 191 (18.9%) reported no problems in any domain. HRQoL index values showed greater variation among those with lower FS (eg, for those with Karnofsky score of 60, the median (IQR) EQ-5D index value was 0.45 (0.24 to 0.68) compared with 0.94 (0.86 to 1) for those with Karnofsky score of 90). Overall, 234 (23.2%) had functional impairment.In multivariable logistic regression models, functional impairment was independently associated with experiencing problems for all EQ-5D-5L domains (mobility: OR 16.87 (95% CI 8.70 to 32.79, p<0.001, self-care: OR 13.08 (95% CI 8.46 to 20.22), p<0.001, usual activities: OR 8.27 (95% CI 5.43 to 12.58), p<0.001, pain/discomfort: OR 2.94 (95% CI 1.86 to 4.67), p<0.001, anxiety/depression: 3.08 (95% CI 2.23 to 4.27), p<0.001). Higher comorbidity count and obesity were independently associated with problems in mobility, self-care, usual activities and pain/discomfort: for three or more comorbidities versus none: (mobility: OR 2.10 (95% CI 1.08 to 4.10, p for trend 0.002), self-care: OR 2.64 (95% CI 0.72 to 9.67, p for trend 0.05), usual activities: OR 4.20 (95% CI 2.02 to 8.74, p for trend <0.001), pain/discomfort: OR 3.06 (95% CI 1.63 to 5.73, p for trend <0.001)), and for obese (body mass index (BMI) ≥30 kg/m 2) versus BMI <25 kg/m 2: (mobility: OR 2.44 (95% CI 1.61 to 3.69, p for trend <0.001), self-care: OR 1.98 (95% CI 1.06 to 3.71, p for trend 0.003), usual activities: OR 1.82 (95% CI 1.19 to 2.76, p for trend 0.019), pain/discomfort: OR 2.37 (95% CI 1.58 to 3.55, p for trend <0.001)). Female sex, lower FS and lower educational attainment were independently associated with anxiety/depression (ORs 1.60 (95% CI 1.18 to 2.16, p 0.002), 3.08 (95% CI 2.23 to 4.27, p<0.001) and 1.67 (95% CI 1.10 to 2.52, p 0.009), respectively). Older age, higher comorbidity count, albuminuria (≥30 mg/mmol vs <3 mg/mmol), lower educational attainment (no formal qualifications vs degree level) and obesity were independently associated with functional impairment (ORs 1.07 (95% CI 1.04 to 1.09, p<0.001), 2.18 (95% CI 0.80 to 5.96, p for trend <0.001), 1.74 (95% CI 0.82 to 3.68, p for trend 0.005), 2.08 (95% CI 1.26 to 3.41, p for trend <0.001) and 4.23 (95% CI 2.48 to 7.20), respectively).

CONCLUSIONS: The majority of persons with mild-to-moderate CKD reported reductions in at least one HRQoL domain, which were independently associated with comorbidities, obesity and functional impairment.

TRIAL REGISTRATION NUMBER: National Institute for Health Research Clinical Research Portfolio Study Number 6632.

chronic renal failure, epidemiology, primary care, public health
2044-6055
1-11
Fraser, Simon
135884b6-8737-4e8a-a98c-5d803ac7a2dc
Barker, Jenny
61fc2078-98d6-4859-a57b-7cbc8afe0dc5
Roderick, Paul
dbb3cd11-4c51-4844-982b-0eb30ad5085a
Yuen, Ho Ming
b1df4c57-0c2a-44ac-ab40-22b88e8effe8
Shardlow, Adam
abbfb299-8658-4670-a958-433654655aa6
Morris, James Edward
631cdf2c-3ddf-41ef-8b74-65a1dffb1e58
McIntyre, Natasha
8c2ce4ad-5acb-4fa8-bdb2-b90dda68a627
Fluck, Richard J.
fedcd5a4-5459-461f-bef0-3747f4a3757d
McIntyre, Christopher W.
567b8ae4-b1dc-4792-bad0-f6dee73305d6
Taal, Maarten W.
10eeea62-a2fc-43b6-b5af-359e75c501ea
Fraser, Simon
135884b6-8737-4e8a-a98c-5d803ac7a2dc
Barker, Jenny
61fc2078-98d6-4859-a57b-7cbc8afe0dc5
Roderick, Paul
dbb3cd11-4c51-4844-982b-0eb30ad5085a
Yuen, Ho Ming
b1df4c57-0c2a-44ac-ab40-22b88e8effe8
Shardlow, Adam
abbfb299-8658-4670-a958-433654655aa6
Morris, James Edward
631cdf2c-3ddf-41ef-8b74-65a1dffb1e58
McIntyre, Natasha
8c2ce4ad-5acb-4fa8-bdb2-b90dda68a627
Fluck, Richard J.
fedcd5a4-5459-461f-bef0-3747f4a3757d
McIntyre, Christopher W.
567b8ae4-b1dc-4792-bad0-f6dee73305d6
Taal, Maarten W.
10eeea62-a2fc-43b6-b5af-359e75c501ea

Fraser, Simon, Barker, Jenny, Roderick, Paul, Yuen, Ho Ming, Shardlow, Adam, Morris, James Edward, McIntyre, Natasha, Fluck, Richard J., McIntyre, Christopher W. and Taal, Maarten W. (2020) Health related quality of life, functional impairment and comorbidity in people with mild to moderate chronic kidney disease: a cross sectional study. BMJ Open, 10 (8), 1-11, [e040286]. (doi:10.1136/bmjopen-2020-040286).

Record type: Article

Abstract

OBJECTIVES: To determine the associations between comorbidities, health-related quality of life (HRQoL) and functional impairment in people with mild-to-moderate chronic kidney disease (CKD) in primary care.

DESIGN: Cross-sectional analysis at 5-year follow-up in a prospective cohort study.

SETTING: Thirty-two general practitioner surgeries in England.

PARTICIPANTS: 1008 participants with CKD stage 3 (of 1741 people recruited at baseline in the Renal Risk in Derby study) who survived to 5 years and had complete follow-up data for HRQoL and functional status (FS).

PRIMARY AND SECONDARY OUTCOME MEASURES: HRQoL assessed using the 5-level EQ-5D version (EQ-5D-5L, with domains of mobility, self-care, usual activities, pain/discomfort and anxiety/depression and index value using utility scores calculated from the English general population), and FS using the Karnofsky Performance Status scale (functional impairment defined as Karnofksy score ≤70). Comorbidity was defined by self-reported or doctor-diagnosed condition, disease-specific medication or blood result.

RESULTS: Mean age was 75.8 years. The numbers reporting some problems in EQ-5D-5L domains were: 582 (57.7%) for mobility, 166 (16.5%) for self-care, 466 (46.2%) for usual activities, 712 (70.6%) for pain/discomfort and 319 (31.6%) for anxiety/depression. Only 191 (18.9%) reported no problems in any domain. HRQoL index values showed greater variation among those with lower FS (eg, for those with Karnofsky score of 60, the median (IQR) EQ-5D index value was 0.45 (0.24 to 0.68) compared with 0.94 (0.86 to 1) for those with Karnofsky score of 90). Overall, 234 (23.2%) had functional impairment.In multivariable logistic regression models, functional impairment was independently associated with experiencing problems for all EQ-5D-5L domains (mobility: OR 16.87 (95% CI 8.70 to 32.79, p<0.001, self-care: OR 13.08 (95% CI 8.46 to 20.22), p<0.001, usual activities: OR 8.27 (95% CI 5.43 to 12.58), p<0.001, pain/discomfort: OR 2.94 (95% CI 1.86 to 4.67), p<0.001, anxiety/depression: 3.08 (95% CI 2.23 to 4.27), p<0.001). Higher comorbidity count and obesity were independently associated with problems in mobility, self-care, usual activities and pain/discomfort: for three or more comorbidities versus none: (mobility: OR 2.10 (95% CI 1.08 to 4.10, p for trend 0.002), self-care: OR 2.64 (95% CI 0.72 to 9.67, p for trend 0.05), usual activities: OR 4.20 (95% CI 2.02 to 8.74, p for trend <0.001), pain/discomfort: OR 3.06 (95% CI 1.63 to 5.73, p for trend <0.001)), and for obese (body mass index (BMI) ≥30 kg/m 2) versus BMI <25 kg/m 2: (mobility: OR 2.44 (95% CI 1.61 to 3.69, p for trend <0.001), self-care: OR 1.98 (95% CI 1.06 to 3.71, p for trend 0.003), usual activities: OR 1.82 (95% CI 1.19 to 2.76, p for trend 0.019), pain/discomfort: OR 2.37 (95% CI 1.58 to 3.55, p for trend <0.001)). Female sex, lower FS and lower educational attainment were independently associated with anxiety/depression (ORs 1.60 (95% CI 1.18 to 2.16, p 0.002), 3.08 (95% CI 2.23 to 4.27, p<0.001) and 1.67 (95% CI 1.10 to 2.52, p 0.009), respectively). Older age, higher comorbidity count, albuminuria (≥30 mg/mmol vs <3 mg/mmol), lower educational attainment (no formal qualifications vs degree level) and obesity were independently associated with functional impairment (ORs 1.07 (95% CI 1.04 to 1.09, p<0.001), 2.18 (95% CI 0.80 to 5.96, p for trend <0.001), 1.74 (95% CI 0.82 to 3.68, p for trend 0.005), 2.08 (95% CI 1.26 to 3.41, p for trend <0.001) and 4.23 (95% CI 2.48 to 7.20), respectively).

CONCLUSIONS: The majority of persons with mild-to-moderate CKD reported reductions in at least one HRQoL domain, which were independently associated with comorbidities, obesity and functional impairment.

TRIAL REGISTRATION NUMBER: National Institute for Health Research Clinical Research Portfolio Study Number 6632.

Text
e040286.full - Version of Record
Available under License Creative Commons Attribution.
Download (623kB)

More information

Accepted/In Press date: 6 July 2020
e-pub ahead of print date: 6 August 2020
Published date: 6 August 2020
Additional Information: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Keywords: chronic renal failure, epidemiology, primary care, public health

Identifiers

Local EPrints ID: 443049
URI: http://eprints.soton.ac.uk/id/eprint/443049
ISSN: 2044-6055
PURE UUID: 84267298-6530-432a-a117-72ee1b52c267
ORCID for Simon Fraser: ORCID iD orcid.org/0000-0002-4172-4406
ORCID for Paul Roderick: ORCID iD orcid.org/0000-0001-9475-6850

Catalogue record

Date deposited: 07 Aug 2020 16:30
Last modified: 17 Mar 2024 03:14

Export record

Altmetrics

Contributors

Author: Simon Fraser ORCID iD
Author: Jenny Barker
Author: Paul Roderick ORCID iD
Author: Ho Ming Yuen
Author: Adam Shardlow
Author: James Edward Morris
Author: Natasha McIntyre
Author: Richard J. Fluck
Author: Christopher W. McIntyre
Author: Maarten W. Taal

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×